A medical degree (MBBS) or a minimum of an upper second-class UK Bachelor’s degree in life or biomedical sciences (for example, neuroscience, pharmacology or chemistry) or an overseas qualification of an equivalent standard. If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency. The English language level for this programme is: Standard. Further information can be found on our English language requirements http://www.ucl.ac.uk/prospective-students/graduate/life/international/english-requirements page.
Months of entry
This programme will provide a world-class education for advanced training in translational research, from preclinical discovery through to first-time-in-man studies in human and clinical trials in healthy volunteers and patients across neurology and neurodegeneration.
The programme is delivered by the UCL Institute of Neurology, a specialist postgraduate institute and a worldwide centre of excellence in clinical research across neurological diseases, including movement disorders (e.g. Parkinson\'s disease), multiple sclerosis, neuro-inflammation, epilepsy, stroke, cognitive dysfunction, Alzheimer\'s Disease and other dementias.
Students will be taught by experts in the field and have the opportunity to network with internationally recognised opinion leaders in neurology and neurodegeneration.
By the end of the programme students will gain a thorough understanding of the challenges involved in setting up research projects, and learn how to design, implement, analyse and report clinical studies. Undertaking an extended piece of primary research in a clinical trials setting is particularly attractive to students wishing to pursue doctoral or clinical research. The focus on translational neurology, from within the specialist research setting of the Leonard Wolfson Experimental Neurology Centre, is also of note.
Qualification and course duration
The programme will combine lectures, workshops and tutorials. Practicals will focus on the role of surrogate markers and emerging technologies in drug development e.g. pre-clinical discovery, first time in man studies, and early phase clinical trials in healthy volunteers and patients. Assessment is through short answer unseen exams, coursework, simulated grant applications and written clinical abstract as well as a small component with a short answer exam.
Course contact details
- +44 (0)20 3370 1214